Lorazepam Dosing for Pediatric Seizure Management
For acute seizure management in pediatric patients, including those with febrile seizures, administer lorazepam 0.05-0.1 mg/kg IV (maximum 4 mg) given slowly at 2 mg/min when seizures last longer than 5 minutes. 1
Acute Seizure Treatment Protocol
First-Line Benzodiazepine Therapy
- Lorazepam is the preferred first-line treatment for prolonged seizures (>5 minutes) in children, administered at 0.05-0.1 mg/kg IV with a maximum single dose of 4 mg, given slowly at 2 mg/min. 1, 2
- The American Academy of Pediatrics recommends benzodiazepines as first-line treatment for any seizure lasting more than 5 minutes, regardless of whether the child has a history of febrile seizures or known epilepsy. 1
- When IV access is not available, rectal diazepam should be administered instead, as IM diazepam has erratic absorption and is not recommended. 3
Clinical Context for Febrile Seizures
- Most febrile seizures are self-limited and resolve spontaneously within 1-2 minutes without requiring medication. 3
- Lorazepam administration is reserved for seizures that continue beyond 5 minutes, as these meet criteria for requiring acute intervention. 1
- The treatment algorithm remains identical whether the child has a history of febrile seizures or is experiencing their first seizure. 1
Important Distinctions: Acute vs. Prophylactic Management
What Lorazepam IS Used For
- Acute termination of active seizures lasting >5 minutes 1, 2
- Emergency seizure control in the hospital or prehospital setting 4
- Lorazepam has demonstrated 100% success rate in terminating convulsive status epilepticus in pediatric patients when used appropriately. 5
What Lorazepam IS NOT Used For
- Prophylactic prevention of febrile seizure recurrence - this is explicitly NOT recommended by the American Academy of Pediatrics. 1, 3
- Long-term seizure prevention in children with simple febrile seizures 1
- Routine anticonvulsant prophylaxis after a first afebrile seizure 2
Critical Management Principles
Why Prophylaxis Is Not Recommended
- The American Academy of Pediatrics explicitly recommends against continuous or intermittent anticonvulsant prophylaxis for simple febrile seizures because potential toxicities clearly outweigh minimal risks. 1, 3
- Simple febrile seizures cause no long-term adverse effects on IQ, academic performance, neurocognitive function, or structural brain damage. 1
- The risk of developing epilepsy after simple febrile seizures is approximately 1% (identical to the general population). 1
- Even children with multiple risk factors (age <12 months at first seizure, family history of epilepsy, multiple simple febrile seizures) have only 2.4% risk of developing epilepsy by age 25 years. 1
Recurrence Risk Does Not Justify Prophylaxis
- Children younger than 12 months at first seizure have approximately 50% probability of recurrent febrile seizures, while those older than 12 months have approximately 30% probability. 1
- Despite these recurrence rates, the harm-benefit analysis clearly favors no prophylactic treatment. 1
- Antipyretics (acetaminophen, ibuprofen) do not prevent febrile seizures or reduce recurrence risk, though they may improve comfort. 1, 3
Common Pitfalls to Avoid
Inappropriate Prophylactic Prescribing
- Never prescribe continuous phenobarbital or valproic acid for simple febrile seizures - these carry unacceptable risks including rare fatal hepatotoxicity (valproic acid), hyperactivity, irritability, lethargy, and cognitive impairment (phenobarbital causes mean IQ reduction of 7 points during treatment). 1
- Do not prescribe intermittent diazepam prophylaxis during febrile illnesses for simple febrile seizures, as it does not improve long-term outcomes and causes lethargy, drowsiness, and ataxia. 1
- Rescue medications (rectal diazepam or buccal midazolam) may be prescribed for patients with known epilepsy, but this is different from prophylactic prevention of febrile seizure recurrence. 1
Appropriate Supportive Care During Seizures
- Position the patient on their side, remove harmful objects, and protect the head from injury. 1
- Never restrain the patient or place anything in the mouth during active seizure activity. 1, 3
- Provide gradual passive cooling for febrile seizures, avoiding rapid cooling measures that may induce shivering. 4
When to Administer Lorazepam
Clear Indications
- Any seizure (febrile or afebrile) lasting longer than 5 minutes 1, 2
- Convulsive status epilepticus 5
- Multiple seizures without return to baseline 3
Administration Details
- Dose: 0.05-0.1 mg/kg IV 1, 2
- Maximum single dose: 4 mg 1
- Rate: 2 mg/min 1
- May require a second dose if seizure does not terminate with initial administration 5
Safety Profile
- Lorazepam is as safe and efficacious as diazepam-phenytoin combination for pediatric convulsive status epilepticus. 5
- Respiratory depression occurs in approximately 4-5% of patients, similar to other benzodiazepines. 5
- No patients in controlled trials required mechanical ventilation when lorazepam was used appropriately. 5